Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Takaharu Hirayama"'
Autor:
Takahito Hara, Satoshi Kitazawa, Misa Iwatani, Hitoshi Miyashita, Ryutaro Adachi, Yukiko Yamamoto, Megumi Morimoto, Takeo Arita, Sou Sakamoto, Takaharu Hirayama, Kazumasa Miyamoto
Publikováno v:
Biochemical and Biophysical Research Communications. 488:648-654
Protein translation is highly activated in cancer tissues through oncogenic mutations and amplifications, and this can support survival and aberrant proliferation. Therefore, blocking translation could be a promising way to block cancer progression.
Autor:
Masanori Okaniwa, Hiroyuki Kakei, Tomoyasu Ishikawa, Tomohiro Kawamoto, Takaharu Hirayama, Akihiro Yokota, Maki Miyamoto, Momoko Ohori, Kenichi Iwai, Hiroshi Banno, Akihiro Ohashi, Tadahiro Nambu
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 26:4296-4300
Centromere-associated protein-E (CENP-E) is a mitotic kinesin which plays roles in cell division, and is regarded as a promising therapeutic target for the next generation of anti-mitotic agents. We designed novel fused bicyclic CENP-E inhibitors sta
Autor:
Koji Ono, Yukiko Hikichi, Masanori Okaniwa, Douglas R. Cary, Maki Hasegawa, Kazunobu Aoyama, Hiroshi Banno, Saomi Murai, Kazuko Yonemori, Yuka Hasegawa, Akito Hata, Takaharu Hirayama, Naoki Iwamura
Publikováno v:
Bioorganicmedicinal chemistry. 25(8)
To develop a novel series of CDK8/19 dual inhibitors, we employed structure-based drug design using docking models based on a library compound, 4,5-dihydroimidazolo[3',4':3,4]benzo[1,2-d]isothiazole 16 bound to CDK8. We designed various [5,6,5]-fused
Autor:
Douglas R. Cary, Kazunobu Aoyama, Yuka Hasegawa, Yasuhiro Hirata, Jun Fujimoto, Kazuko Yonemori, Takaharu Hirayama, Akito Hata, Yukiko Hikichi, Maki Hasegawa, Saomi Murai
Publikováno v:
Bioorganicmedicinal chemistry. 25(12)
In this article, synthetic studies around a pyridylacrylamide-based hit compound (1), utilizing structure-based drug design guided by CDK8 docking models, is discussed. Modification of the pendant 4-fluorophenyl group to various heteroaromatic rings
Autor:
Akira Hori, Yoshiko Awazu, Terufumi Takagi, Yuya Oguro, Nozomu Sakai, Takaharu Hirayama, Kengo Okada, Naoki Miyamoto, Hideyuki Oki, Hiroshi Miki, Shinichi Imamura, Hidehisa Iwata, Toshiyuki Takeuchi, Seiji Yamasaki, Kazuhiro Miwa
Publikováno v:
Bioorganic & Medicinal Chemistry. 21:2333-2345
Vascular endothelial growth factor (VEGF) plays important roles in tumor angiogenesis, and the inhibition of its signaling pathway is considered an effective therapeutic option for the treatment of cancer. In this study, we describe the design, synth
Publikováno v:
Chemistry - An Asian Journal. 4:1298-1303
Treatment of alpha,beta-unsaturated ketones with an electrophilic site at the gamma-position in the presence of trimethylsilyl cyanide with bis(iodozincio)methane afforded the (Z)-silyl enol ether of the beta-cyclopropyl substituted ketone in good yi
Autor:
Akihiro Ohashi, Kouji Mori, Hiroshi Banno, Takaharu Hirayama, Gotou Mika, Hiroyuki Kakei, Tomoyasu Ishikawa, Tomohiro Kawamoto, Momoko Ohori, Kenichi Iwai, Akihiro Yokota, Masanori Okaniwa
Publikováno v:
Journal of medicinal chemistry. 58(20)
To develop centromere-associated protein-E (CENP-E) inhibitors for use as anticancer therapeutics, we designed novel imidazo[1,2-a]pyridines, utilizing previously discovered 5-bromo derivative 1a. By site-directed mutagenesis analysis, we confirmed t
Publikováno v:
Angewandte Chemie. 117:3357-3360
Autor:
Hiroshi Banno, Tomohiro Kawamoto, Daisuke Morishita, Takaharu Hirayama, Kenichi Iwai, Kentaro Iwata, Momoko Ohori, Tomoyasu Ishikawa, Akihiro Ohashi, Yusuke Nakayama, Tadahiro Nambu, Maki Miyamoto, Masanori Okaniwa, Hitoshi Kandori
Publikováno v:
Nature Communications
The molecular mechanism responsible that determines cell fate after mitotic slippage is unclear. Here we investigate the post-mitotic effects of different mitotic aberrations—misaligned chromosomes produced by CENP-E inhibition and monopolar spindl
Autor:
Takaharu Hirayama, Hideyuki Oki, Naoki Miyamoto, Shinichi Imamura, Michiko Tawada, Kazuhide Nakamura, Hidehisa Iwata, Akira Hori, Hiroshi Miki, Seiji Yamasaki, Shigemitsu Matsumoto, Kengo Okada
Publikováno v:
Bioorganicmedicinal chemistry. 21(24)
To identify compounds with potent antitumor efficacy for various human cancers, we aimed to synthesize compounds that could inhibit c-mesenchymal epithelial transition factor (c-Met) and vascular endothelial growth factor receptor 2 (VEGFR2) kinases.